Welcome to EQUITY DEVELOPMENT

The UK's longest established regulated provider of sponsored equity research.

We launched EQUITY DEVELOPMENT in 1997 becoming the first ever  regulated provider of Sponsored Equity Research in the UK.

Our research teams are made up of expert analysts with deep understanding & experience in their sectors.  Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).

We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.

 

FREE REGISTRATION

Sign up today and access the very latest company research

LOG IN

For access to all company research please

Deltex Medical

Deltex Medical Group Plc (Deltex Medical) is a medical technology company focused on the development, assembling and marketing of a minimally invasive, real-time  cardiac function monitoring system, which uses Doppler (ultrasound) technology.

Deltex Medical; positive pre-close trading update

  • Evidence of growing demand in the UK and US
  • ED forecasts unchanged
  • Fair value 26p vs current 17.5p

 

Publication Date:
January 16 2007

Deltex Medical; steady progress

  • Direct sales are up by 20%
  • Recurring probe sales now 84% of total revenue
  • Successful acquisition and integration of TECO
  • Fair value 26p vs current price 18.5p

Publication Date:
October 25 2006

Deltex Medical; innovative technology positioned to target huge market

  • CardioQ seen as priority device by NHS
  • Three quarters of revenues recurring
  • Cash should last through to profitability
  • Fair value 26.6p vs current 21p

Publication Date:
April 26 2006

previous